#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Progressive multifocal leukoencephalopathy Juvenile chronic myelomonocytic leukaemia Insulinoma Pancreatic carcinoma Bone marrow disorder Congenital hypotransferrinaemia Hypoxic-ischaemic encephalopathy Granulomatosis with polyangiitis Squamous cell carcinoma of the hypopharynx Glomerulonephritis membranous Synovitis Interstitial lung disease Neoplasm Systemic candida Anti-neutrophil cytoplasmic antibody positive vasculitis More trials…

    Learn about Rare Diseases

    CADASIL – Treatment Undifferentiated sarcoma – Treatment Nephroblastoma – Treatment Leukoencephalopathy – Treatment Soft tissue sarcoma Medulloblastoma recurrent Hypereosinophilic syndrome – Life with Disease Isodicentric chromosome 15 syndrome – Treatment Hereditary neuropathic amyloidosis – Diagnostics Chordoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mva-Hbvac Setmelanotide Pabinafusp Alfa Levodopa RPTR-1-201 Sodium S-Lactate Solution Remdesivir Fluorescein Sodium Acenocoumarol Dicloxacillin Sotagliflozin AMO959 Ivacaftor ROC-101 HYDROCHLORIDE Cefiderocol Ovolecithin Sodium Chloride Ph. Eur. ZOREVUNERSEN SODIUM Trabectedin ATIGOTATUG More therapies…

    Learn about Your Condition

    Influenza Embolism Immune-mediated renal disorder Osteotomy Cardiac failure congestive Richter's syndrome Habitual abortion Cerebrovascular accident Haemorrhagic stroke Metastatic malignant melanoma Diffuse large B-cell lymphoma Thyroid mass Cardiac amyloidosis Agitation postoperative Dent's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study on the Effects of Sabirnetug for Patients with Early Alzheimer’s Disease

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Florbetapir (18F)
    • Flutemetamol (18F)
    • Sabirnetug
    France Germany Spain

  • Study of Fentanyl Continuous Infusion in Newborns with Hypoxic Ischemic Brain Injury During Cooling Therapy

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Hypoxic-ischaemic encephalopathy
    Investigated Drugs:
    • Fentanyl Citrate
    Italy

  • Study on the Effect of Clozapine on Immune Response in Patients with Parkinson’s Disease

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Clozapine
    France

  • Study on Trametinib for Patients with Neurofibromatosis Type 1 and Symptomatic Plexiform Neurofibromas

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Neurofibromatosis
    Investigated Drugs:
    • Trametinib
    The Netherlands

  • Comparison of Surgical Treatment versus Cabergoline in Patients with Newly Diagnosed Microprolactinomas

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Prolactin-producing pituitary tumour
    Investigated Drugs:
    • Cabergoline
    Italy

  • Study of KYV-101 Therapy for Patients with Refractory Primary and Secondary Progressive Multiple Sclerosis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Nervous system disorder
    • Progressive multiple sclerosis
    Investigated Drugs:
    • Kyv-101
    • Ofatumumab
    • Ublituximab
    Austria Belgium Germany Italy
Previous Page
1 … 74 75 76 77 78 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!